本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protalix BioTherapeutics Inc

2.69
-0.0100-0.37%
盤後2.700.0100+0.37%19:30 EDT
成交量:124.95萬
成交額:336.38萬
市值:2.16億
市盈率:11.38
高:2.72
開:2.68
低:2.66
收:2.70
52周最高:3.19
52周最低:1.60
股本:8,042.12萬
流通股本:7,653.64萬
量比:1.65
換手率:1.63%
股息:- -
股息率:- -
每股收益(TTM):0.2364
每股收益(LYR):-0.0841
淨資產收益率:31.23%
總資產收益率:15.42%
市淨率:3.03
市盈率(LYR):-31.99

資料載入中...

2021/07/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/07

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

重要事件披露

8-K - Current report
2021/06/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/02

重要事件披露

8-K - Current report
2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

重要事件披露

8-K - Current report
2021/04/30

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/28

重要事件披露

8-K - Current report
2021/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/30

重要事件披露

8-K - Current report
2021/02/23

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals